Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for PD-1 and PD-L1 Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China PD-1 and PD-L1 Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States PD-1 and PD-L1 Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, PD-1 Monoclonal Antibody segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Liver Cancer has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of PD-1 and PD-L1 Drug include Bristol Myers Squibb, Merck & Co., Inc., F. Hoffmann -La Roche Ltd, AstraZeneca, Sanofi, Pfizer Inc, Lilly, Novartis AG and GSK, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
PD-1/PD-L1 is an important part of the human immune system-a drug target on T cells. Drugs designed for this target can activate the immune effect of T cells on tumor cells, thereby awakening the patient's own anti-cancer effect. tumor effect.
This report aims to provide a comprehensive study of the global market for PD-1 and PD-L1 Drug. Report Highlights:
(1) Global PD-1 and PD-L1 Drug market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global PD-1 and PD-L1 Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China PD-1 and PD-L1 Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global PD-1 and PD-L1 Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global PD-1 and PD-L1 Drug segment by type and by application and regional segment by type and by application.
(6) Global major production regions of PD-1 and PD-L1 Drug, capacity, production and trends.
(7) PD-1 and PD-L1 Drug industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
PD-1 Monoclonal Antibody
PD-L1 Monoclonal Antibody
Market segment by application, can be divided into
Liver Cancer
Esophageal Cancer
Nasal Cancer
Stomach Cancer
Other
Market segment by players, this report covers
Bristol Myers Squibb
Merck & Co., Inc.
F. Hoffmann -La Roche Ltd
AstraZeneca
Sanofi
Pfizer Inc
Lilly
Novartis AG
GSK
Junshi Biosciences
Akeso, Inc
BeiGene
Innovent
Jiangsu Hengrui Medicine Co.,Ltd
Cstone
Henlius
Simcere Pharmaceutical Group Limited
- 1.1 Research Objective
- 1.2 Scope of the Study
- 1.3 Definition
- 1.4 Assumptions & Limitations
Chapter 2: Executive Summary
- 2.1 Market Snapshot
Chapter 3: Market Dynamics Analysis and Trends
- 3.1 Market Dynamics
- 3.1.1 Market Growth Drivers
- 3.1.2 Market Restraints
- 3.1.3 Available Market Opportunities
- 3.1.4 Influencing Trends
Chapter 4: Market Factor Analysis
- 4.1 Porter’s Five Forces Analysis
- 4.2 Bargaining power of suppliers
- 4.3 Bargaining power of buyers
- 4.4 Threat of substitute
- 4.5 Threat of new entrants
- 4.6 Porter's Five Forces Analysis
- 4.7 Value Chain Analysis
- 4.8 Market Impact Analysis
- 4.9 Regional Impact
- 4.10 Pricing Analysis
- 4.11 Import-Export Analysis
Chapter 5: Competitive Landscape
- 5.1 Company Market Share/Positioning Analysis
- 5.2 Key Strategies Adopted by Players
- 5.3 Vendor Landscape
- 5.3.1 List of Suppliers
- 5.3.2 List of Buyers
Chapter 6: Analyst Viewpoint and Conclusion
- 6.1 Recommendations and Concluding Analysis
- 6.2 Potential Market Strategies
Chapter 7: RESEARCH METHODOLOGY
- 7.1 Overview
- 7.2 Data Mining
- 7.3 Secondary Research
- 7.4 Primary Research
- 7.4.1 Primary Interviews and Information Gathering Process
- 7.4.2 Breakdown of Primary Respondents
- 7.5 Forecasting Model
- 7.6 Market Size Estimation
- 7.6.1 Bottom-Up Approach
- 7.6.2 Top-Down Approach
- 7.7 Data Triangulation
- 7.8 Validation
Research Methodology:
Global PD 1 and PD L1 Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|